All Search Results
News Releases
Jul 30, 2026, 14:34 ET West Los Angeles Practice ShanthiMD Dermatology Joins Golden State Dermatology
lasting patient relationships, and an exceptional patient experience.Dr. Colaço is a board-certified dermatologist and Fellow of the American Academy of Dermatology who specializes in diagnosing and treating a wide range of conditions affecting the skin, hair, and nails, including acne, eczema, psoriasis,
More news about: Golden State Dermatology
Jul 22, 2026, 08:31 ET SKNV Announces Exclusive Commercialization Rights to Washington University Patent Portfolio Covering Combination of Fluorouracil and Calcipotriene Therapies
of Actinic Keratosis. Journal of the American Academy of Dermatology. 2021;84(4):e209-e233.Que SKT, Zwald FO, Schmults CD. Cutaneous Squamous Cell Carcinoma: Incidence, Risk Factors, Diagnosis, and Staging. Journal of the American Academy of Dermatology. 2018;78(2):237-247.Mary
More news about: SKNV
Jul 16, 2026, 09:59 ET Curology and Walmart Join Forces to Expand Access to Prescription Acne Care Nationwide
Deserts""Dermatologist deserts" are regions with fewer than four dermatologists per 100,000 residents, according to data published in the Journal of the American Academy of Dermatology (
More news about: Curology
Jul 01, 2026, 02:53 ET SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market
1. American Cancer Society. Cancer Facts & Figures 2025. (Melanoma incidence and ranking in the United States.)2. American Academy of Dermatology. Approximately 5.4 million cases of basal cell carcinoma and squamous cell carcinoma are diagnosed annually in the United States.This
More news about: SciBase
Jun 26, 2026, 16:50 ET SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
ReferencesMenter A et al. (2020). Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. Journal of the American Academy of Dermatology, 82(1), 161–201.
More news about: AbbVie